Margit Spatzenegger

630 total citations
13 papers, 562 citations indexed

About

Margit Spatzenegger is a scholar working on Pharmacology, Oncology and Pharmacology. According to data from OpenAlex, Margit Spatzenegger has authored 13 papers receiving a total of 562 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pharmacology, 6 papers in Oncology and 3 papers in Pharmacology. Recurrent topics in Margit Spatzenegger's work include Pharmacogenetics and Drug Metabolism (8 papers), Drug Transport and Resistance Mechanisms (5 papers) and Analytical Chemistry and Chromatography (2 papers). Margit Spatzenegger is often cited by papers focused on Pharmacogenetics and Drug Metabolism (8 papers), Drug Transport and Resistance Mechanisms (5 papers) and Analytical Chemistry and Chromatography (2 papers). Margit Spatzenegger collaborates with scholars based in Austria, United States and Belgium. Margit Spatzenegger's co-authors include Walter Jaeger, James R. Halpert, Emily E. Scott, Roger K. Verbeeck, Yves Horsmans, Hong Liu, Andrea E. DeBarber, Dennis R. Koop, Michaela Miksits and Marek Murias and has published in prestigious journals such as Blood, Journal of Pharmacology and Experimental Therapeutics and Archives of Biochemistry and Biophysics.

In The Last Decade

Margit Spatzenegger

13 papers receiving 541 citations

Peers

Margit Spatzenegger
Nancy Eddy Hopkins United States
Jason S. Ngui United States
Jasleen K. Sodhi United States
Jackie C. Bloomer United Kingdom
Michael P. Pritchard United Kingdom
Paul Toren United States
Yasuhiro Masubuchi Japan
Katsuhiro Ohyama Japan
Toshio Teramura Japan
Donald E. Slaughter United States
Nancy Eddy Hopkins United States
Margit Spatzenegger
Citations per year, relative to Margit Spatzenegger Margit Spatzenegger (= 1×) peers Nancy Eddy Hopkins

Countries citing papers authored by Margit Spatzenegger

Since Specialization
Citations

This map shows the geographic impact of Margit Spatzenegger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Margit Spatzenegger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Margit Spatzenegger more than expected).

Fields of papers citing papers by Margit Spatzenegger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Margit Spatzenegger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Margit Spatzenegger. The network helps show where Margit Spatzenegger may publish in the future.

Co-authorship network of co-authors of Margit Spatzenegger

This figure shows the co-authorship network connecting the top 25 collaborators of Margit Spatzenegger. A scholar is included among the top collaborators of Margit Spatzenegger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Margit Spatzenegger. Margit Spatzenegger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Dietrich, Barbara, Margit Spatzenegger, Reinhard Stidl, et al.. (2011). Safety of Baxter’s Longer Acting rFVIII (BAX 855) After Repeated Application in Rats and Cynomolgus Monkeys. Blood. 118(21). 4345–4345. 4 indexed citations
2.
Murias, Marek, Michaela Miksits, Sylvia Aust, et al.. (2007). Metabolism of resveratrol in breast cancer cell lines: Impact of sulfotransferase 1A1 expression on cell growth inhibition. Cancer Letters. 261(2). 172–182. 50 indexed citations
3.
Spatzenegger, Margit, et al.. (2003). Analysis of Differential Substrate Selectivities of CYP2B6 and CYP2E1 by Site-Directed Mutagenesis and Molecular Modeling. Journal of Pharmacology and Experimental Therapeutics. 304(1). 477–487. 65 indexed citations
4.
Spatzenegger, Margit, et al.. (2001). Amino Acid Residues Critical for Differential Inhibition of CYP2B4, CYP2B5, and CYP2B1 by Phenylimidazoles. Molecular Pharmacology. 59(3). 475–484. 34 indexed citations
5.
Scott, Emily E., Margit Spatzenegger, & James R. Halpert. (2001). A Truncation of 2B Subfamily Cytochromes P450 Yields Increased Expression Levels, Increased Solubility, and Decreased Aggregation While Retaining Function. Archives of Biochemistry and Biophysics. 395(1). 57–68. 129 indexed citations
6.
Spatzenegger, Margit, et al.. (2001). Amino Acid Residues Critical for Differential Inhibition of CYP2B4, CYP2B5, and CYP2B1 by Phenylimidazoles. Molecular Pharmacology. 59(3). 475–484. 5 indexed citations
7.
Spatzenegger, Margit, Yves Horsmans, & Roger K. Verbeeck. (2000). CYP1A1 but Not CYP1A2 Proteins are Expressed in Human Lymphocytes. Pharmacology & Toxicology. 86(5). 242–244. 10 indexed citations
8.
Spatzenegger, Margit, Yves Horsmans, & Roger K. Verbeeck. (2000). Differential Activities of CYP1A Isozymes in Hepatic and Intestinal Microsomes of Control and 3-Methylcholanthrene-Induced Rats. Pharmacology & Toxicology. 86(2). 71–77. 35 indexed citations
9.
Spatzenegger, Margit, Yves Horsmans, & Roger K. Verbeeck. (2000). Differential Activities of CYP1A Isozymes in Hepatic and Intestinal Microsomes of Control and 3‐Methylcholanthrene‐Induced Rats. Pharmacology & Toxicology. 86(2). 71–77. 10 indexed citations
10.
Spatzenegger, Margit, Yves Horsmans, & Roger K. Verbeeck. (2000). CYP1A1 but Not CYP1A2 Proteins are Expressed in Human Lymphocytes. Pharmacology & Toxicology. 86(5). 242–244. 4 indexed citations
11.
Spatzenegger, Margit, Gerhard F. Ecker, & Walter Jäger. (1996). Determination of the New MDR-Modifier PFP 6 and its Metabolites in Human Liver Microsomes by High-Performance Liquid Chromatography. Biomedical Chromatography. 10(3). 127–130. 3 indexed citations
12.
Spatzenegger, Margit, et al.. (1996). Metabolism of dextromethorphan in human liver microsomes: a rapid HPCL assay to monitor cytochrome P450 2D6 activity.. PubMed. 51(8). 586–8. 7 indexed citations
13.
Spatzenegger, Margit & Walter Jaeger. (1995). Clinical Importance of Hepatic Cytochrome P450 in Drug Metabolism. Drug Metabolism Reviews. 27(3). 397–417. 206 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nancy Eddy Hopkins Breakdown of academic impact, for papers by Jason S. Ngui Breakdown of academic impact, for papers by Jasleen K. Sodhi Breakdown of academic impact, for papers by Jackie C. Bloomer Breakdown of academic impact, for papers by Michael P. Pritchard Breakdown of academic impact, for papers by Paul Toren Breakdown of academic impact, for papers by Yasuhiro Masubuchi Breakdown of academic impact, for papers by Katsuhiro Ohyama Breakdown of academic impact, for papers by Toshio Teramura Breakdown of academic impact, for papers by Donald E. Slaughter
Rankless by CCL
2026